Anti-Microbial Coating Innovations to prevent infectious disease: a consensus view from the AMiCI COST Action

Four years ago, when AMiCI was established, there was clear evidence that antimicrobial resistance (AMR) had emerged as a global health risk. While effective and prudent stewardship of antimicrobial products were being promoted as necessary for management and potential mitigation of this risk, there was increasing recognition of the possibilities that antimicrobial coatings (AMCs) presented. AMCs and some associated technologies were not necessarily new. For

Proactive Approach for Safe Use of Antimicrobial Coatings in Healthcare Settings

First opinion paper of the COST Action Network AMiCI have been published in The International Journal of Environmental Research and Public Health. We publish here the abstract (1) and  conclusions (5). 1.The abstract: Infections and infectious diseases are considered a major challenge to human health in healthcare units worldwide. This opinion paper was initiated by EU COST Action network AMiCI (AntiMicrobial Coating Innovations) and focuses on scientific information essential